Radiation-Induced Neuropsychiatric Manifestations in a Patient with Brain Metastasis: A Diagnostic and Therapeutic Challenges for Consultation-Liaison Psychiatrist

por Padma, Kumari, Nanaware, Sagar, Pande, Nikhil, Ransing, Ramdas, Kulkarni, Krishnaji
Publicado 2018

Pazopanib use preceding curative surgery in low rectal gastrointestinal stromal tumors after imatinib failure: A case report

por Pande, Nikhil, Shetty, Omshree, Boppana, Mounika, Ramaswamy, Anant, Saklani, Avanish, Shetty, Nitin, Ostwal, Vikas
Publicado 2019

Effect of Mindfulness-Based Art Therapy (MBAT) on Psychological Distress and Spiritual Wellbeing in Breast Cancer Patients Undergoing Chemotherapy

por Joshi, Anjali Mangesh, Mehta, Suchitra Ajay, Pande, Nikhil, Mehta, Ajay Omprakash, Randhe, Kamaljeet Sanjay
Publicado 2021

ROS1 mutation non-small cell lung cancer—access to optimal treatment and outcomes

por Joshi, Amit, Pande, Nikhil, Noronha, Vanita, Patil, Vijay, Kumar, Rajiv, Chougule, Anuradha, Trivedi, Vaishakhi, Janu, Amit, Mahajan, Abhishek, Prabhash, Kumar
Publicado 2019

Third-line therapy in the epidermal growth factor receptor mutation-positive advanced nonsmall-cell lung cancer

por Noronha, Vanita, Pande, Nikhil, Joshi, Amit, Patil, Vijay, Trivedi, Vaishakhi, Chougule, Anuradha, Janu, Amit, Mahajan, Abhishek, Talreja, Vikas, Prabhash, Kumar
Publicado 2020

Shadow study: randomized comparison of clinic with video follow-up in glioma undergoing adjuvant temozolomide therapy

por Patil, Vijay M, Pande, Nikhil, Chandrasekharan, Arun, M, Chandrakanth, Tonse, Raees, Krishnatry, Rahul, Goda, Jayant S, Dsouza, Hollis, Vallathol, Dilip Harindran, Chakraborty, Santam, Gupta, Tejpal, Jalali, Rakesh
Publicado 2018

Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patients

por Patil, Vijay, Joshi, Amit, Noronha, Vanita, Bhattacharjee, Atanu, Dhumal, Sachin, Chandrakanth, M. V., Karpe, Ashay, Talreja, Vikas, Chandrasekharan, Arun, Turkar, Siddharth, Pande, Nikhil, Ramaswamy, Anant, Prabhash, Kumar
Publicado 2018

Distress Management in Patients With Head and Neck Cancer Before Start of Palliative Chemotherapy: A Practical Approach

por Patil, Vijay, Noronha, Vanita, Joshi, Amit, Deodhar, Jayita, Goswami, Savita, Chakraborty, Santam, Ramaswamy, Anant, Dhumal, Sachin, M.V., Chandrakanth, Karpe, Ashay, Pande, Nikhil, Talreja, Vikas, Chandrasekharan, Arun, Turkar, Siddharth, Prabhash, Kumar
Publicado 2018

Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell l...

por Patil, Vijay, Joshi, Amit, Noronha, Vanita, Agarwala, Vivek, Chougule, Anuradha, Kanan, Sadhana, Bhattacharjee, Atanu, Chandrasekharan, Arun, Pande, Nikhil, Simha, Vijai, Goud, Supriya, More, Sucheta, Kumar, Rajiv, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Publicado 2019

Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed–carboplatin chemotherapy

por Noronha, Vanita, Patil, Vijay, Joshi, Amit, Chougule, Anuradha, Bhattacharjee, Atanu, Kumar, Rajiv, More, Sucheta, Goud, Supriya, Karpe, Ashay, Ramaswamy, Anant, Pande, Nikhil, Chandrasekharan, Arun, Goel, Alok, Talreja, Vikas, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Publicado 2017

Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?

por Joshi, Amit, Patil, Vijay, Noronha, Vanita, Chougule, Anuradha, Bhattacharjee, Atanu, Kumar, Rajiv, Goud, Supriya, More, Sucheta, Ramaswamy, Anant, Karpe, Ashay, Pande, Nikhil, Chandrasekharan, Arun, Goel, Alok, Talreja, Vikas, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Publicado 2018

Efficacy of Second-Line Pemetrexed-Carboplatin in EGFR-Activating Mutation-Positive NSCLC: Does Exon 19 Deletion Differ from Exon 21 Mutation?

por Joshi, Amit, Noronha, Vanita, Patil, Vijay M., Chougule, Anuradha, Bhattacharjee, Atanu, Kumar, Rajiv, Goud, Supriya, More, Sucheta, Ramaswamy, Anant, Karpe, Ashay, Pande, Nikhil, Chandrasekharan, Arun, Goel, Alok, Talreja, Vikas, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Publicado 2017

Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

por Patil, Vijay Maruti, Noronha, Vanita, Joshi, Amit, Choughule, Anuradha Bharat, Bhattacharjee, Atanu, Kumar, Rajiv, Goud, Supriya, More, Sucheta, Ramaswamy, Anant, Karpe, Ashay, Pande, Nikhil, Chandrasekharan, Arun, Goel, Alok, Talreja, Vikas, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Publicado 2017

Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer - An Indian exploratory ana...

por Ramaswamy, Anant, Ostwal, Vikas, Pande, Nikhil, Sharma, Atul, Patil, Shekar, Thippeswamy, Ravi, Ghadyalpatil, Nikhil, Roy, Rakesh, Peshwe, Harish, Poladia, Bhavesh, Rajamanickam, Deepan, Rangarajan, Bharat, Neelesh Reddy, P. R., Pandita, Vimal, Mukherjee, Ashis, Thoke, Aniket, Sarkar, Abhijit, Satish, C. T., Shashidara, H., Banavali, S. D.
Publicado 2019

Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trial

por Patil, Vijay M., Menon, Nandini, Chatterjee, Abhishek, Tonse, Raees, Choudhari, Amit, Mahajan, Abhishek, Puranik, Ameya D., Epari, Sridhar, Jadhav, Monica, Pathak, Shruti, Peelay, Zoya, Walavalkar, Rutuja, Muthuluri, Hemanth K., Ravi Krishna, Madala, Chandrasekharan, Arun, Pande, Nikhil, Gupta, Tejpal, Banavali, Shripad, Jalali, Rakesh
Publicado 2022